SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 26, 2018 (February 22, 2018)
CHEMBIO DIAGNOSTICS, INC.
(Exact name of registrant as specified in its charter)
|
Nevada
|
0-30379
|
88-0425691
|
||
|
(State or other jurisdiction
|
(Commission File Number)
|
(IRS Employer
|
||
|
of Incorporation)
|
Identification Number)
|
|||
|
3661 Horseblock Road
|
||||
|
Medford, NY 11763
|
||||
|
(Address of principal executive offices)
|
||||
|
631-924-1135
|
||||
|
(Registrant's Telephone Number)
|
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 7.01.
REGULATION FD DISCLOSURE.
On February 22, 2018, the Company issued a press release entitled "Chembio Diagnostics to Report Fourth Quarter and 2017 Financial Results on March 8, 2018". A copy of the press release is filed herewith as Exhibit 99.1.
ITEM 9.01.
FINANCIAL STATEMENTS AND EXHIBITS
Exhibits.
|
99.1
|
Press Release entitled "Chembio Diagnostics to Report Fourth Quarter and 2017 Financial Results on March 8, 2018" dated February 22, 2018.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
February 26, 2018
Chembio Diagnostics, Inc.
By:
/s/ John J. Sperzel III
John J. Sperzel III
Chief Executive Officer
EXHIBIT INDEX
|
Exhibit Number
|
Description
|
|
99.1
|
Press Release entitled "Chembio Diagnostics to Report Fourth Quarter and 2017 Financial Results on March 8, 2018" dated February 22, 2018.
|
